Self-sampling Blood Collection and Storage Device Market 2022 | Growth Strategies, Opportunity, Challenges, Rising Trends and Revenue Analysis 2030

The latest market report published by Credence Research, Inc. “Global Self-sampling Blood Collection and Storage Device Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for Self-sampling Blood Collection and Storage Devices was worth USD 0.18 billion in 2022 and is predicted to reach USD 0.39 billion in 2030, rising at an 11.70% CAGR between 2023 and 2030.

Self-sampling Blood Collection and Storage Device Market represents a rapidly growing segment within the healthcare and diagnostics industry. This market revolves around innovative devices designed to enable individuals to collect their own blood samples easily and conveniently for various diagnostic purposes. These self-sampling devices often incorporate user-friendly features such as painless blood collection techniques, minimal discomfort, and user instructions, making them accessible to a wide range of users, including those outside traditional healthcare settings.

Once collected, the blood samples can be stored in integrated or accompanying storage solutions, preserving sample integrity until analysis. This market’s growth is driven by factors such as increased awareness of preventive healthcare, the convenience of at-home sample collection, and the rise of personalized medicine. Furthermore, the ongoing development of novel self-sampling and storage technologies, coupled with their potential for early disease detection and management, positions this market as a significant contributor to advancing healthcare accessibility and diagnostics in a patient-centric manner.

The dynamics of the Self-sampling Blood Collection and Storage Device Market are influenced by a complex interplay of factors that shape its growth, adoption, and evolution within the healthcare and diagnostics industry. These dynamics encompass various trends, challenges, opportunities, and market drivers, all of which contribute to the market’s trajectory.

Here are the key dynamics at play:

Rising Demand for At-Home Healthcare: The increasing preference for at-home healthcare solutions, driven by convenience and the need for social distancing, fuels the demand for self-sampling blood collection devices. These devices empower individuals to monitor their health without the need for frequent clinic visits.

Preventive Healthcare Awareness: Growing awareness of the importance of preventive healthcare and regular health monitoring encourages individuals to use self-sampling devices for early disease detection, wellness tracking, and health management.

Expansion of Personalized Medicine: The trend toward personalized medicine, which relies on individualized diagnostic data, boosts the adoption of self-sampling devices. These devices allow for the collection of specific data points needed for personalized treatment plans.

Technological Advancements: Ongoing technological advancements, including improved blood collection techniques and integrated storage solutions, enhance the usability and accuracy of self-sampling devices, making them more attractive to users.

Pandemic-Driven Shift: The COVID-19 pandemic has accelerated the adoption of remote healthcare solutions, including self-sampling devices, as people seek alternatives to in-person healthcare visits.

The regional analysis of the Self-sampling Blood Collection and Storage Device Market reveals variations in market dynamics, adoption rates, and key trends across different geographic regions. These variations are influenced by factors such as healthcare infrastructure, regulatory frameworks, technological advancements, and population demographics. Here is a regional breakdown of the market:

North America: North America, including the United States and Canada, is a significant market for self-sampling blood collection and storage devices. The region’s advanced healthcare infrastructure, strong focus on preventive healthcare, and high consumer awareness drive market growth. The COVID-19 pandemic has accelerated the adoption of remote healthcare solutions in this region.

Europe: European countries, such as the United Kingdom, Germany, France, and the Nordic countries, have a well-established healthcare system and a growing interest in personalized medicine. The market benefits from favorable reimbursement policies and a proactive approach to healthcare, supporting the adoption of self-sampling devices.

Asia-Pacific: The Asia-Pacific region, including countries like China, India, Japan, and South Korea, offers substantial growth opportunities. Rising healthcare expenditure, increasing awareness of chronic diseases, and a large population base contribute to the market’s expansion. Additionally, the penetration of e-commerce and digital health solutions boosts access to self-sampling devices.

Latin America: Latin American countries, such as Brazil and Mexico, are witnessing a gradual adoption of self-sampling blood collection and storage devices. The market growth is driven by healthcare reforms, improving access to healthcare services, and a growing focus on early disease detection.

Browse 245 pages report By Product (Collection Devices, Others) By Application (Disease Management, Health & Wellness, Drug, Discovery & Development, Epidemiological Population Health Studies, Others) By Customer Base (Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical Industries, Home Settings, Others) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030)

These strategic moves often involve collaborations between device manufacturers, healthcare providers, and technology companies.

Here are some examples of partnerships and acquisitions in this market:

Thermo Fisher Scientific’s Acquisition of Phadia: Thermo Fisher Scientific, a global leader in healthcare and diagnostics, acquired Phadia, a provider of in-vitro diagnostic solutions. This acquisition strengthened Thermo Fisher’s portfolio with advanced diagnostic technologies, including blood collection and testing devices.

Roche’s Partnership with Novartis: Roche, a major player in the healthcare industry, partnered with Novartis to develop innovative self-sampling and diagnostic solutions. This collaboration aimed to advance personalized medicine and remote patient monitoring.

LabCorp’s Partnership with EverlyWell: Laboratory Corporation of America Holdings (LabCorp) partnered with EverlyWell, a digital health company, to offer self-collected at-home lab tests. This partnership provided consumers with convenient access to various self-sampling kits for health monitoring.

BD’s Acquisition of Accuri Cytometers: BD (Becton, Dickinson and Company), a global medical technology company, acquired Accuri Cytometers, a manufacturer of flow cytometry systems. This acquisition expanded BD’s capabilities in cell analysis and self-sampling solutions.

Telemedicine Companies and Device Manufacturers: Various telemedicine companies have partnered with device manufacturers to integrate self-sampling solutions into their platforms. These partnerships offer patients access to remote testing and consultations.

Digital Health Startups and Laboratories: Emerging digital health startups often collaborate with accredited laboratories to provide self-sampling kits and diagnostic services. These partnerships facilitate the delivery of test results and medical guidance through digital platforms.

Acquisitions in the Molecular Diagnostics Sector: Companies specializing in molecular diagnostics and genetic testing have acquired or partnered with self-sampling device manufacturers to offer comprehensive genetic testing solutions to consumers.

Retail Pharmacy Chains and Device Suppliers: Retail pharmacy chains have entered partnerships with self-sampling device suppliers to expand their product offerings, providing consumers with over-the-counter self-sampling kits.

Why to Buy This Report-

  • The report provides a qualitative as well as quantitative analysis of the global Self-sampling Blood Collection and Storage Device Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
  • The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
  • Major nations in each region with their import/export statistics
  • The global Self-sampling Blood Collection and Storage Device Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major player analysis, market growth strategies, and key application areas.

Browse Full Report:


Related Report:

Related Report:

Browse Our Blog:

About Us –

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

Leave a Reply

Your email address will not be published.